ES2570962T3 - Producción incrementada de un producto diana vía estabilización del ARNm - Google Patents
Producción incrementada de un producto diana vía estabilización del ARNmInfo
- Publication number
- ES2570962T3 ES2570962T3 ES08801456T ES08801456T ES2570962T3 ES 2570962 T3 ES2570962 T3 ES 2570962T3 ES 08801456 T ES08801456 T ES 08801456T ES 08801456 T ES08801456 T ES 08801456T ES 2570962 T3 ES2570962 T3 ES 2570962T3
- Authority
- ES
- Spain
- Prior art keywords
- polynucleotide
- microorganism
- vitamin
- production
- target product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 4
- 230000012976 mRNA stabilization Effects 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 abstract 6
- 239000002157 polynucleotide Substances 0.000 abstract 6
- 102000040430 polynucleotide Human genes 0.000 abstract 6
- 244000005700 microbiome Species 0.000 abstract 4
- 239000011782 vitamin Substances 0.000 abstract 4
- 229940088594 vitamin Drugs 0.000 abstract 4
- 229930003231 vitamin Natural products 0.000 abstract 4
- 235000013343 vitamin Nutrition 0.000 abstract 4
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
- C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/167—Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/185—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system
- C12P17/186—Heterocyclic compounds containing sulfur atoms as ring hetero atoms in the condensed system containing a 2-oxo-thieno[3,4-d]imidazol nucleus, e.g. Biotin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P25/00—Preparation of compounds containing alloxazine or isoalloxazine nucleus, e.g. riboflavin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
Un procedimiento para la producción de una vitamina con un microorganismo, en el que dicho microorganismo se incuba en un medio acuoso en condiciones que permiten la producción de dicha vitamina a partir de una fuente de carbono, y en el que opcionalmente se aísla la vitamina, en el que dicho microorganismo se altera genéticamente mediante introducción de un polinucleótido que conduce a un rendimiento y/o eficiencia mejorados de la producción de la vitamina producida por dicho microorganismo, seleccionándose dicho polinucleótido del grupo que consiste en: (a) polinucleótidos que comprenden la secuencia nucleotídica según SEC ID NO:2; (b) y polinucleótidos que son al menos 95% idénticos a un polinucleótido como se define en (a) y que tiene la actividad de un elemento estabilizador del ARNm, o la hebra complementaria de tal polinucleótido.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07011200A EP2000477A1 (en) | 2007-06-07 | 2007-06-07 | Increased production of a target product via stabilization of mRNA |
| EP07011415 | 2007-06-11 | ||
| EP07011681 | 2007-06-14 | ||
| PCT/EP2008/004583 WO2008148575A2 (en) | 2007-06-07 | 2008-06-09 | Increased production of a target product via stabilization of mrna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2570962T3 true ES2570962T3 (es) | 2016-05-23 |
Family
ID=39731439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08801456T Active ES2570962T3 (es) | 2007-06-07 | 2008-06-09 | Producción incrementada de un producto diana vía estabilización del ARNm |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8551732B2 (es) |
| EP (1) | EP2150559B1 (es) |
| KR (1) | KR101558622B1 (es) |
| CN (1) | CN101679490B (es) |
| ES (1) | ES2570962T3 (es) |
| WO (1) | WO2008148575A2 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012175575A2 (en) | 2011-06-21 | 2012-12-27 | Dsm Ip Assets B.V. | Increased vitamin b5 production |
| WO2012175574A1 (en) | 2011-06-21 | 2012-12-27 | Dsm Ip Assets B.V. | Increased pantothenate (vitamin b5) production |
| WO2013086219A1 (en) * | 2011-12-09 | 2013-06-13 | Danisco Us Inc. | Ribosomal promotors from b. subtilis for protein production in microorganisms |
| EP2996697B1 (en) | 2013-05-15 | 2019-06-26 | Robert Kruse | Intracellular translation of circular rna |
| WO2015118126A1 (en) * | 2014-02-07 | 2015-08-13 | Dsm Ip Assets B.V. | Improved bacillus host |
| US20180030456A1 (en) * | 2015-02-19 | 2018-02-01 | Danisco Us Inc. | Enhanced protein expression |
| CN107922464B (zh) * | 2015-08-28 | 2022-03-15 | 帝斯曼知识产权资产管理有限公司 | 经改进的维生素生产 |
| WO2021224152A1 (en) | 2020-05-05 | 2021-11-11 | Basf Se | Improving expression in fermentation processes |
| WO2022018268A1 (en) | 2020-07-24 | 2022-01-27 | Basf Se | Alanine racemase double deletion and transcomplementation |
| WO2022074056A2 (en) | 2020-10-07 | 2022-04-14 | Basf Se | Bacillus cell with reduced lipase and/or esterase side activities |
| WO2022161914A1 (en) | 2021-01-26 | 2022-08-04 | Basf Se | High temperature fermentation process and microorganisms |
| US20240317820A1 (en) | 2021-06-24 | 2024-09-26 | Basf Se | Improved bacillus production host |
| WO2022269081A1 (en) | 2021-06-24 | 2022-12-29 | Basf Se | Bacillus licheniformis host cell for production of a compound of interest with increased purity |
| CN117693587A (zh) | 2021-06-24 | 2024-03-12 | 巴斯夫欧洲公司 | 具有改变的RemA/RemB蛋白的改良芽孢杆菌宿主细胞 |
| EP4453218A1 (en) | 2021-12-20 | 2024-10-30 | Basf Se | Method for improved production of intracellular proteins in bacillus |
| WO2024146919A1 (en) | 2023-01-05 | 2024-07-11 | Basf Se | Use of foldases to improve heterologous expression of secreted molecules |
| WO2025166052A1 (en) * | 2024-01-30 | 2025-08-07 | Parcel Biosciences, Inc. | Stabilized mrna complexes and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017477A (en) * | 1985-10-25 | 1991-05-21 | Biotechnica International, Inc. | Enhancing DNA sequencies derived from the sacQ gene |
| CN1962872A (zh) * | 2005-11-07 | 2007-05-16 | 上海市肿瘤研究所 | 特异性切割血管内皮生长因子rna的核酶及其应用 |
| CN101336295B (zh) | 2005-12-05 | 2013-07-17 | 帝斯曼知识产权资产管理有限公司 | 用于mRNA稳定的方法 |
-
2008
- 2008-06-09 ES ES08801456T patent/ES2570962T3/es active Active
- 2008-06-09 EP EP08801456.8A patent/EP2150559B1/en not_active Not-in-force
- 2008-06-09 CN CN200880019197.6A patent/CN101679490B/zh not_active Expired - Fee Related
- 2008-06-09 US US12/601,614 patent/US8551732B2/en not_active Expired - Fee Related
- 2008-06-09 KR KR1020107000214A patent/KR101558622B1/ko not_active Expired - Fee Related
- 2008-06-09 WO PCT/EP2008/004583 patent/WO2008148575A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2150559B1 (en) | 2016-02-10 |
| US8551732B2 (en) | 2013-10-08 |
| US20100173356A1 (en) | 2010-07-08 |
| WO2008148575A3 (en) | 2009-04-23 |
| CN101679490A (zh) | 2010-03-24 |
| WO2008148575A2 (en) | 2008-12-11 |
| EP2150559A2 (en) | 2010-02-10 |
| CN101679490B (zh) | 2014-05-07 |
| KR101558622B1 (ko) | 2015-10-07 |
| KR20100018044A (ko) | 2010-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2570962T3 (es) | Producción incrementada de un producto diana vía estabilización del ARNm | |
| NZ700645A (en) | Processing biomass | |
| WO2013032850A3 (en) | Compositions and methods for high fidelity assembly of nucleic acids | |
| MY201125A (en) | Novel promoter and method for producing purine nucleotide using the same | |
| NZ595476A (en) | Plant snf1-related protein kinase gene | |
| AR055169A1 (es) | Metodos para el control genetico de infestaciones de insectos en plantas y composiciones para los mismos | |
| AR047166A1 (es) | Promotor de metalotioneina de maiz | |
| ES2692918T3 (es) | Métodos y composiciones para producir aldehídos grasos | |
| IN2012DN01652A (es) | ||
| NZ586643A (en) | Woody plants having improved growth characteristics and method for making the same using transcription factors | |
| AR065327A1 (es) | Polinucleotidos para el control de nematodos parasitarios y metodo para su uso en plantas | |
| AR065281A1 (es) | Proteinas de tipo trehalasa par el control de nematodos y metodos para su uso en plantas | |
| AR109207A1 (es) | Control de plagas de coleópteros utilizando moléculas de arn | |
| MX2013011601A (es) | Promotor especifico de semilla en alogodon. | |
| RU2016130093A (ru) | Трансформант для экспрессии цис-пренилтрансферазы и рецептора Nogo-B | |
| MX377843B (es) | Uso de una xilanasa en maíz y sub-productos de maíz. | |
| AR109205A1 (es) | Control de plagas de coleópteros utilizando moléculas de arn | |
| DK201070194A (en) | A method of stabilizing mRNA | |
| AR083445A1 (es) | siARN CONTRA LA FIBROSIS | |
| AR107504A1 (es) | Secuencia de nucleótidos y método para controlar invasiones de insectos | |
| AR078502A1 (es) | Regulacion hacia abajo de acc (acido 1-aminociclopropano-1-carboxilico) sintasa para el rendimiento mejorado de plantas | |
| MX2016015036A (es) | Endoproteasa especifica para prolina. | |
| AR103920A1 (es) | Moléculas de ácido nucleico de ii215 de arn polimerasa para el control de plagas de insectos | |
| AR107868A1 (es) | Elementos reguladores vegetales y sus usos | |
| AR094337A1 (es) | Método y composiciones para el control genético de insectos plaga en plantas de algodón a través del silenciamiento de genes de quitina sintasas |